Comparison of efficacy and safety of different tourniquet applications in total knee arthroplasty: a network meta-analysis of randomized controlled trials

Figures & data

Figure 1. ▪ ▪ ▪.

Figure 2. ▪ ▪ ▪.

Figure 3. ▪ ▪ ▪.

Table 1. The detailed results of conventional pair-wise meta-analyses.

Comparison (use vs. not use of tourniquet)	No. of trials	No. of patients	Diagnosis	Heterogeneity, I^2	Effect index	Effect size
Operation time	17	1324	Osteoarthritis Rheumatoid arthritis Revision	79.90%	WMD with 95%CI	–3.991
						(–7.143 to −0.839)
Itraoperative blood loss	10	703	Osteoarthritis Rheumatoid arthritis	88.20%	WMD with 95%CI	–142.861
						(–175.053 to −110.669)
Postoperative blood loss	6	431	Osteoarthritis Rheumatoid arthritis	59.10%	WMD with 95%CI	81.281
						(35.233 to 127.329)
Total blood loss	15	1110	Osteoarthritis Rheumatoid arthritis Revision	92.20%	WMD with 95%CI	–79.279
						(–177.341 to 18.783)
Knee flexion range	6	676	Osteoarthritis Rheumatoid arthritis	39.30%	WMD with 95%CI	–0.785
						(–2.598 to 1.028)
Early postoperative function	5	452	Osteoarthritis Rheumatoid arthritis	71.60%	SMD with 95%CI	–0.304
						(–0.682 to 0.073)
Late postoperative function	4	288	Osteoarthritis Rheumatoid arthritis	0.00%	SMD with 95%CI	0.045
						(–0.186 to 0.277)
Early postoperative pain	8	788	Osteoarthritis Rheumatoid arthritis	97.30%	SMD with 95%CI	0.23
						(–0.733 to 1.194)
Late postoperative pain	7	716	Osteoarthritis Rheumatoid arthritis	73.40%	SMD with 95%CI	–0.036
						(–0.340 to 0.268)
Incidence of DVT	10	881	Osteoarthritis Rheumatoid arthritis Revision	0.00%	OR with 95%CI	1.394
						(0.879 to 2.209)
Minor complication	6	629	Osteoarthritis Rheumatoid arthritis	0.00%	OR with 95%CI	1.306
						(0.846 to 2.017)
Major complication	3	341	Osteoarthritis Rheumatoid arthritis	0	OR with 95%CI	0.945
						(0.251 to 3.555)

Data availability statement

The authors confirm that the data supporting the findings of this study are available within the article and its supplementary materials.